Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005375 |
ID: | TCMBANKHE005375 |
植物拉丁名: |
|
功能与主治: | To warm lung and transform rheum, dissipate cold and relieve pain./Phlegm-rheum cough asthma, cold pain in stomach duct and abdomen, intestinal wind blood dysentery, amenorrhea and dysmenorrhea, cold mounting with abdominal pain, toothache, bad breath. |
药用植物名: | 桂花 |
药用部位: | flower |
TCM_ID_id: | 3388 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000098 | linamarin | CHEBI:16441; 2-(beta-D-Glucopyranosyloxy)-2-methylpropionitrile; SR-05000002494-1; CTK8G0586; BSPBio_003283; KBioSS_002500; BICL4127; SCHEMBL42021; FT-0608720; KBio2_007628; 1-cyano-1-methylethyl beta-D-glucoside; KBio3_002503; C01594; Spectrum_001946; SpecPlus_000936; Spectrum3_001622; CCG-39428; 2-beta-d-glucopyranosyloxy-2-methylpropanenitrile; CHEMBL3039425; 2-(; LINAMARIN; SPBio_002123; KBio1_001976; W-203090; alpha-Hydroxyisobutyronitrile beta-D-glucopyranoside, >=98.0% (HPLC); Propanenitrile, 2-(beta-D-glucopyranosyloxy)-2-methyl-; NCGC00178164-01; 2-Methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)propanenitrile; 5-17-07-00397 (Beilstein Handbook Reference); AKOS030242445; MFCD00036209; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-propanenitrile; alpha-Hydroxyisobutyronitrile beta-D-glucopyranoside; Linamarin; LS-120874; Spectrum5_000575; DTXSID8052857; Manihotoxin; KBio2_005060; SR-05000002494; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-propionitrile; KBio2_002492; H3V9RP3WLO; UNII-H3V9RP3WLO; BRN 0019237; 2-(beta-D-Glucopyranosyloxy)-2-methyl-Propanenitrile; DivK1c_007032; 2-(beta-D-Glucopyranosyloxy)-2-methylpropanenitrile; HSDB 3507; alpha-Hydroxyisobutyronitrile-beta-D-glucose; 2-(beta-D-Glucopyranosyloxy)isobutyronitrile; A-D-Glucopyranosyloxy)-2-methyl-propanenitrile; Spectrum2_001972; alpha-Hydroxyisobutyronitrile beta-D-glucose; 2-methyl-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]propanenitrile; C-51988; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-propanenitrile; MolPort-003-665-717; A-D-Glucopyranosyloxy)-2-methylpropionitrile; ZINC3984017; Phaseolunatin; KBioGR_002195; 2-(b-D-Glucopyranosyloxy)-2-methylpropanenitrile, 9CI; SPECTRUM1504124; SDCCGMLS-0066829.P001; 2-methyl-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanenitrile; Spectrum4_001668; AC1L1WOH; 554-35-8; AK600739; 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanenitrile | C10H17NO6 | 247.24 g/mol | CC(C)(C#N)OC1C(C(C(C(O1)CO)O)O)O |
| TCMBANKIN019175 | dihydroisoalantolactone | AC1O535W; Decahydro-3,8a-dimethyl-5-methylenenaphtho(2,3-b)furan-2(3H)-one (3S-(3alpha,3abeta,4abeta,8aalpha,9abeta))-; CHEMBL486423; Naphtho(2,3-b)furan-2(3H)-one, decahydro-3,8a-dimethyl-5-methylene-, (3S-(3alpha,3abeta,4abeta,8aalpha,9abeta))-; 11,13-Dihydroisoalantolactone; (3S,3aR,4aS,8aR,9aR)-3,8a-dimethyl-5-methylidene-3a,4,4a,6,7,8,9,9a-octahydro-3H-benzo[f][1]benzofuran-2-one; Dihydroisoalantolactone; 1856-58-2 | C15H22O2 | 234.33 g/mol | CC1C2CC3C(=C)CCCC3(CC2OC1=O)C |
| TCMBANKIN045822 | Dihydro-beta-ionone | EINECS 241-318-1; CHEBI:18015; Dihydro-; I14-18428; AK-60960; MolPort-003-721-207; SCHEMBL441670; .alpha.,.beta.-Dihydro-.beta.-ionone; OXIDIZED-LATIA-LUCIFERIN; AN-18697; 17283-81-7; CAS-17283-81-7; Dihydro-beta-ionone, >=90%; Dihydro-.beta.-ionone; AI3-32482; CHEMBL3188345; ZINC2565574; W362603_ALDRICH; 710YK6CESE; LS-2671; InChI=1/C13H22O/c1-10-6-5-9-13(3,4)12(10)8-7-11(2)14/h5-9H2,1-4H; Oxidized Latia luciferin; FEMA No. 3626; 4-(2,6,6-trimethylcyclohexen-1-yl)butan-2-one; UNII-710YK6CESE; 7,8-Dihydro-.beta.-ionone; Dihydro-b-ionone; 7,8-Dihydro-beta-ionone; .beta.-Ionone, dihydro-; QJJDNZGPQDGNDX-UHFFFAOYSA-N; AKOS015903877; 4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-butanone, 9CI; dihydro-beta-ionone; 4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-one; 4-(2,6,6-trimethyl-cyclohex-1-enyl)-butan-2-one; dihydro-β-ionone; 4-(2,6,6-trimethyl-1-cyclohexenyl)butan-2-one; DSSTox_CID_27200; STOCK1N-72264; 4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-butanone; DSSTox_GSID_47200; AC1LAS8K; 2-Butanone, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-; C03527; ZINC02565574; DSSTox_RID_82195; Tox21_302666; Dihydro Lonone Beta; 4-(2,6,6-trimethylcyclohex-1-enyl)butan-2-one; 1-(1,1,5-Trimethylcyclohex-5-en-6-yl)-butan-3-one; 7,8-Dehydro-beta-ionone; 4-(2,6,6-trimethyl-1-cyclohexenyl)-butan-2-one; A-ionone; 5-Megastigmen-9-one; 4-(2,6,6-trimethyl-cyclohex-1 -enyl)-butan-2-one; FT-0725907; .beta.-7,8-Dihydroionone; alpha,beta-Dihydro-beta-ionone; DTXSID4047200; NCGC00256712-01; 4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)butan-2-one; Latia oxyluciferin; 4-(2,6,6-Trimethyl-1-cyclohexenyl)-2-butanone; AJ-41132 | C13H22O | 194.31 | CC1=C(C(CCC1)(C)C)CCC(=O)C |
| TCMBANKIN059587 | inalool oxide | C10H18O2 | 170.25 g/mol | CC1(CCC(O1)C(C)(C)O)C=C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab